Impact of ticagrelor with or without aspirin on total and recurrent bleeding and ischaemic events after percutaneous coronary intervention: a sub-study of the TWILIGHT trial

MLA

Baber, Usman, et al. “Impact of Ticagrelor with or without Aspirin on Total and Recurrent Bleeding and Ischaemic Events after Percutaneous Coronary Intervention: A Sub-Study of the TWILIGHT Trial.” European Heart Journal - Cardiovasular Pharmacotherapy, vol. 11, no. 1, Jan. 2025, pp. 66–74. EBSCOhost, https://doi.org/10.1093/ehjcvp/pvae080.

APA

Baber, U., Cao, D., Collier, T., Sartori, S., Dangas, G., Angiolillo, D. J., Vogel, B., Kunadian, V., Briguori, C., Cohen, D. J., Dudek, D., Gibson, C. M., Gil, R., Huber, K., Kaul, U., Kornowski, R., Krucoff, M. W., Mehta, S., Moliterno, D. J., … Mehran, R. (2025). Impact of ticagrelor with or without aspirin on total and recurrent bleeding and ischaemic events after percutaneous coronary intervention: a sub-study of the TWILIGHT trial. European Heart Journal - Cardiovasular Pharmacotherapy, 11(1), 66–74. https://doi.org/10.1093/ehjcvp/pvae080

Chicago

Baber, Usman, Davide Cao, Timothy Collier, Samantha Sartori, George Dangas, Dominick J Angiolillo, Birgit Vogel, et al. 2025. “Impact of Ticagrelor with or without Aspirin on Total and Recurrent Bleeding and Ischaemic Events after Percutaneous Coronary Intervention: A Sub-Study of the TWILIGHT Trial.” European Heart Journal - Cardiovasular Pharmacotherapy 11 (1): 66–74. doi:10.1093/ehjcvp/pvae080.